Stockscreener 앱 받기
10.28
4.73%
-0.51
시간 외 거래:
10.28
전일 마감가:
$10.79
열려 있는:
$10.86
하루 거래량:
112.47K
Relative Volume:
0.60
시가총액:
$340.08M
수익:
$65.42M
순이익/손실:
$-32.96M
주가수익비율:
-8.0945
EPS:
-1.27
순현금흐름:
$-19.87M
1주 성능:
-5.86%
1개월 성능:
+6.31%
6개월 성능:
-3.38%
1년 성능:
+65.54%
1일 변동 폭
$10.25
$11.25
1주일 범위
$10.25
$11.25
52주 변동 폭
$5.45
$18.98
뉴로페이스 Stock (NPCE) Company Profile
명칭
Neuropace Inc
전화
(650) 237-2700
주소
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
NPCE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
10.28 | 356.95M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
뉴로페이스 Stock (NPCE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-28 | 개시 | H.C. Wainwright | Buy |
| 2025-01-21 | 개시 | UBS | Buy |
| 2024-03-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | 개시 | Leerink Partners | Outperform |
| 2023-11-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-08-24 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-02-22 | 개시 | Lake Street | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-18 | 개시 | Robert W. Baird | Outperform |
| 2021-05-17 | 개시 | JP Morgan | Overweight |
| 2021-05-17 | 개시 | Morgan Stanley | Overweight |
| 2021-05-17 | 개시 | SVB Leerink | Outperform |
| 2021-05-17 | 개시 | Wells Fargo | Overweight |
모두보기
뉴로페이스 주식(NPCE)의 최신 뉴스
NeuroPace's (NPCE) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Automated trading signals detected on NeuroPace Inc.Trade Analysis Summary & Free Technical Pattern Based Buy Signals - newser.com
What momentum shifts mean for NeuroPace Inc.2025 Market Overview & Community Consensus Stock Picks - newser.com
NeuroPace Inc. recovery potential after sell offInsider Selling & Verified Swing Trading Watchlist - newser.com
What analysts say about NeuroPace Inc stockEx-Dividend Date Alerts & Stay One Step Ahead of Risk Events - earlytimes.in
NeuroPace, Inc. (NASDAQ:NPCE) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
NeuroPace Inc Stock Analysis and ForecastDouble Top/Bottom Patterns & Affordable Portfolio Growth - earlytimes.in
Using economic indicators to assess NeuroPace Inc. potentialJuly 2025 Setups & AI Powered Market Entry Ideas - newser.com
HighMark Wealth Management LLC Purchases 60,000 Shares of NeuroPace, Inc. $NPCE - MarketBeat
Neuropace chief medical officer Morrell sells $48,032 in stock - MSN
What drives NeuroPace Inc stock priceTrading Volume Surges & Get Mentorship from Elite Traders - earlytimes.in
Epilepsy Treatment Devices Market Hits New High | Medtronic, NeuroPace, LivaNova, Boston Scientific - newstrail.com
Why NeuroPace Inc. stock is trending among retail tradersJuly 2025 Final Week & Growth Focused Stock Pick Reports - The British Mountaineering Council
Palumbo Wealth Management LLC Grows Stake in NeuroPace, Inc. $NPCE - MarketBeat
Why NeuroPace Inc. is moving todayGap Down & Comprehensive Market Scan Reports - newser.com
Will NeuroPace Inc. outperform the marketWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Is NeuroPace Inc. building a consolidation baseInsider Selling & Short-Term Swing Trade Alerts - newser.com
NeuroPace Inc. stock prediction for this weekPortfolio Gains Report & Safe Entry Zone Identification - newser.com
Forecasting NeuroPace Inc. price range with options data2025 Short Interest & Target Return Focused Stock Picks - newser.com
NeuroPace, Inc. (NASDAQ:NPCE) Looks Just Right With A 25% Price Jump - simplywall.st
Using Vision Transformers for Electrographic Seizure Classification to Aid Physician Review of Intracranial Electroencephalography Recordings - Frontiers
How to recover losses in NeuroPace Inc. stock2025 Top Decliners & Short-Term Swing Trade Alerts - newser.com
NeuroPace, Inc. (NASDAQ:NPCE) Receives $16.60 Consensus Target Price from Analysts - MarketBeat
NeuroPace raises FY25 revenue view to $94M-$98M, consensus $94.78M - MSN
Aug Sectors: What makes NeuroPace Inc stock attractive today2025 Key Lessons & Fast Momentum Entry Tips - خودرو بانک
Brokerages Set NeuroPace, Inc. (NASDAQ:NPCE) Price Target at $16.60 - Defense World
Will NeuroPace Inc. stock recover after earningsMarket Movement Recap & Short-Term High Return Ideas - خودرو بانک
뉴로페이스 (NPCE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
뉴로페이스 주식 (NPCE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Morrell Martha | CHIEF MEDICAL OFFICER |
Feb 21 '25 |
Sale |
13.72 |
78,334 |
1,074,844 |
81,993 |
| KCK LTD. | 10% Owner |
Feb 20 '25 |
Sale |
9.40 |
5,270,845 |
49,545,943 |
0 |
| Morrell Martha | CHIEF MEDICAL OFFICER |
Jan 30 '25 |
Sale |
15.00 |
200 |
3,000 |
86,762 |
| Morrell Martha | CHIEF MEDICAL OFFICER |
Jan 29 '25 |
Sale |
15.00 |
100 |
1,500 |
86,962 |
1.83%
자본화:
|
볼륨(24시간):